Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Pfizer Inc
Pfizer Inc And Renovis Inc
Pfizer Inc Products Inc
Pfizer Inc Pfizer Products Inc
  

Pfizer Inc patents

Recent patent applications related to Pfizer Inc. Pfizer Inc is listed as an Agent/Assignee. Note: Pfizer Inc may have other listings under different names/spellings. We're not affiliated with Pfizer Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "P" | Pfizer Inc-related inventors




Date Pfizer Inc patents (updated weekly) - BOOKMARK this page
12/07/17 new patent  Substituted carbonucleoside derivatives useful as anticancer agents
11/23/17Compositions comprising heterogeneous populations of recombinant human clotting factor xa proteins
11/16/17Sulfonyl amide derivatives for the treatment of abnormal cell growth
11/09/17Enhanced stability of novel liquid compositions
11/02/17Interferon beta antibodies and uses thereof
11/02/17Engineered polypeptide conjugates and methods for making thereof using transglutaminase
10/26/17Sglt-2 inhibitors for treating metabolic disorders in patients with renal impairment or chronic kidney disease
10/26/172-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8h)-yl-1,3-thiazol-4-yl amides
10/26/17N-[2-(2-amino-6,6-disubstituted-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8h)-yl)-1,3-thiazol-4-yl] amides
10/26/17Treatment with anti-pcsk9 antibodies
10/19/17Substituted dihydroisoquinolinone compounds
10/05/17Bruton's tyrosine kinase inhibitors
09/28/17Crystalline solid forms of 6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole
09/28/17Combination of a pd-1 antagonist and an alk inhibitor for treating cancer
09/28/172-thiopyrimidinones
09/28/17Benzenesulfonamides useful as sodium channel inhibitors
09/28/17Egfrviii specific chimeric antigen receptor for cancer immunotherapy
09/21/17Pemetrexed polymeric nanoparticles and methods of making and using same
09/21/17Methods of treating cancers with therapeutic nanoparticles
09/07/17Methods of use and combinations
08/31/17Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof
08/31/17Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamides
08/31/17Anti-il-7r antibody compositions
08/24/17Aminopyrimidinyl compounds
08/24/17Pyrazolo[1,5-a]pyrazin-4-yl derivatives
08/17/17Aryl and heteroaryl fused lactams
08/17/17Rorc2 inhibitors and methods of use thereof
08/17/17Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of rorc2 and methods of use thereof
08/10/17Therapeutic nanoparticles having egfr ligands and methods of making and using same
08/10/17Glycoconjugation processes and compositions
08/10/17Fgf23 fusion proteins
08/03/17Dual-ended lip balm container
08/03/17Dual-ended lip balm container
08/03/17Antibodies and antibody fragments for site-specific conjugation
08/03/17Novel 3-amino-pyrrolo[3,4-c]pyrazole-5(1h, 4h,6h) carbaldehyde derivatives
07/27/17Methods of controlling the morphology of polymeric nanoparticles
07/27/17Chimeric antigen receptors targeting epidermal growth factor receptor variant iii
07/27/17Antibodies specific for epidermal growth factor receptor variant iii and their uses
07/20/17Apixaban formulations
07/20/17Apixaban formulations
07/20/17Dosage forms of apixaban
07/20/17Cancer vaccines
07/20/17Pyrazolopyrimidine compounds
07/13/17Tropomyosin-related kinase inhibitors containing both a 1h-pyrazole and a pyrimidine moiety
07/06/17Stable formulations for lyophilizing therapeutic particles
07/06/17Salt forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid
06/29/17Rsv f protein mutants
06/29/17Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors
06/29/17Cancer treatment
06/22/17Combination of a pd-1 antagonist and a 4-1bb agonist for treating cancer
06/15/17Heteroaromatic compounds and their use as dopamine d1 ligands
06/15/17Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of asgpr
06/15/17Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative diseases
06/15/17Combination of a pd-1 antagonist and a vegfr inhibitor for treating cancer
06/01/17Methods of treating cancers with therapeutic nanoparticles
06/01/172-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8h)-yl-1,3-thiazol-4-yl amides
06/01/17Site specific her2 antibody drug conjugates
06/01/17Benzamide and heterobenzamide compounds
05/25/17Imidazopyridazine compounds
05/18/17Tissue-specific genome engineering using crispr-cas9
05/11/17Targeted therapeutic nanoparticles and methods of making and using same
05/04/17Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same
04/27/17Anti-il-2 antibodies and compositions and uses thereof
04/20/17Method of cell culture
04/06/17Novel cyclopropabenzofuranyl pyridopyrazinediones
Patent Packs
03/30/17N-[2-(3-amino-2,5-dimethyl-1,1-dioxido-5,6-dihydro-2h-1,2,4-thiadiazin-5-yl)-1,3-thiazol-4-yl] amides
03/30/17N-(2-(2-amino-6-substituted-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]oxazin-8a(8h)-yl)-thiazol-4-yl) amides
03/30/17N-[2-(2-amino-6,6-disubstituted-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8h)-yl)-1,3-thiazol-4-yl]amides
03/30/17Combination of an anti-ccr4 antibody and a 4-1bb agonist for treating cancer
03/16/17Pyrazolopyridines and pyrazolopyrimidines
03/16/17Crystalline form of 6-[(4r)-4-methyl-1,2-dioxido-1,2,6-thiadiazinan-2-yl]isoquinoline-1-carbonitrile
03/16/17Novel imidazo[4,5-c]quinoline and imidazo[4,5-c][1,5]naphthyridine derivatives as lrrk2 inhibitors
03/16/17Humanized antibodies
03/16/17Tissue factor pathway inhibitor antibodies and uses thereof
03/16/17Anti-efna4 antibody-drug conjugates
03/09/17Physiologically-relevant affinity measurements in vitro with backscattering interferometry
03/02/17Heteroaromatic compounds and their use as dopamine d1 ligands
02/23/17Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same
02/23/17Cycloalkyl-linked diheterocycle derivatives
02/23/17Antibodies to madcam
Patent Packs
02/16/17Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same
02/16/17Antibody-drug conjugates with high drug loading
02/16/17Heterocyclic compounds and their use as dopamine d1 ligands
02/09/17Therapeutic polymeric nanoparticles comprising corticosteroids and methods of making and using same
02/09/17Heteroaromatic compounds and their use as dopamine d1 ligands
02/09/17Heteroaromatic compounds and their use as dopamine d1 ligands
02/02/171,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as magl inhibitors
01/26/17Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
01/19/17Spliceostatin analogs and methos for their preparation
01/19/17Anti-notch3 antibodies and antibody-drug conjugates
01/19/17Pyrimidine derivatives
01/12/17Immunogenic glycoprotein conjugates
01/12/172-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8h)-yl-1,3-thiazol-4-yl amides
01/05/17Novel 3,4-disubstituted-1h-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7h-pyrrolo[2,3-c]pyridazines as lrrk2 inhibitors
01/05/17Sulfonyl amide derivatives for the treatment of abnormal cell growth
12/29/16Prostate-associated antigens and vaccine-based immunotherapy regimens
12/29/16Compositions and methods for treating intracerebral hemorrhage
12/29/16Substituted dihydroisoquinolinone compounds
12/22/16Novel pyridine pyrazinones as bet-family bromodomain inhibitors
12/22/164-1bb binding molecules
12/15/16Glucagon receptor modulators
12/01/16N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors
12/01/16Bicyclic-fused heteroaryl or aryl compounds
12/01/16Neisseria meningitidis composition and methods thereof
11/17/16Process for annealing amorphous atorvastatin
11/10/16Streptococcus pneumoniae capsular polysaccharides and conjugates thereof
11/10/16Streptococcus pneumoniae capsular polysaccharides and conjugates thereof
11/10/16Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
11/10/162-thiopyrimidinones
10/27/16Anti-estrogenic compounds
Social Network Patent Pack
10/20/16Diacylglycerol acyltransferase 2 inhibitors
10/20/162-thiopyrimidinones
10/13/16Chimeric antigen receptors targeting b-cell maturation antigen
10/13/16Therapeutic antibodies and their uses
09/22/16Bifunctional cytotoxic agents containing the cti pharmacophore
09/22/16Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof
09/22/16Novel 3-indol substituted derivatives, pharmaceutical compositions and methods for use
09/15/16Apixaban liquid formulations
09/01/16Intermediates and methods for synthesizing calicheamicin derivatives
08/25/16Apixaban formulations
Patent Packs
08/25/16Substituted nucleoside derivatives useful as anticancer agents
08/18/16Vectors for expression of prostate-associated antigens
08/11/16Novel bicyclic pyridinones as gamma-secretase modulators
08/04/16Use of acetyl-coa carboxylase inhibitors for treating acne vulgaris
08/04/16Combination therapy for tuberculosis
08/04/16N-acylpyrrolidine ether tropomyosin-related kinase inhibitors
08/04/16Novel cyclopropabenzofuranyl pyridopyrazinediones
07/21/16Crizotinib for use in the treatment of cancer
07/21/16Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of asgpr
07/21/16Therapeutic antibody
07/14/16Oral delivery product
07/14/16Heteroaromatic compounds and their use as dopamine d1 ligands
07/07/16Recombinant virus-like particles encoded by multi-gene vector
06/30/16Salt forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid
06/30/16Solid forms of a transthyretin dissociation inhibitor
06/23/16Conjugates and associated methods of producing them for the prevention or treatment of nicotine addiction
06/23/16Modified polysaccharides for conjugate vaccines
06/23/16Axl inhibitors
06/23/16Antagonists of prostaglandin ep3 receptor
06/02/16Enhanced stability of novel liquid compositions
06/02/162-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8h)-yl-1,3-thiazol-4-yl amides
06/02/16Antibodies to cd40
06/02/16Combinations of anti-4-1bb antibodies and adcc-inducing antibodies for the treatment of cancer
06/02/16Treatment with anti-pcsk9 antibodies
05/19/16Cold therapy device
05/19/16Use of a tetrasubstituted pyrazolo[4, 3-d]pyrimidine compound for treating diabetic nephropathy
05/12/16Sulfonyl amide derivatives for the treatment of abnormal cell growth
05/05/16Fecal recovery assay
04/28/16Solid forms of a macrocyclic kinase inhibitor
04/21/16Oligomers targeting hexanucleotide repeat expansion in human c9orf72 gene
Patent Packs
04/14/16Substituted amide compounds
04/07/16Antibodies to insulin-like growth factor i receptor
04/07/16Pc33718e
03/31/16Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of rorc2 and methods of use thereof
03/03/16Substituted amide compounds
03/03/16Cancer treatment
02/25/16Aminopyrimidinyl compounds
02/18/16Pyrrolo[2,3-d]pyrimidine derivatives
02/18/16Rorc2 inhibitors and methods of use thereof
02/11/16Imidazopyridazine compounds
02/11/16Humanized antibodies specific for staphylococcal enterotoxin b
02/04/16Neisseria meningitidis compositions and methods thereof
01/28/16Spliceostatin analogs and methods for their preparation
01/28/16Novel pyrido[1,2-a]pryazines and their use in the treatment of neurodegenerative and neurological disorders
01/21/16Pyridine derivatives as muscarinic m1 receptor positive allosteric modulators
01/21/16Indole and indazole compounds that activate ampk
01/21/16Immunogenic fusion polypeptides
01/21/16Indole and indazole compounds that activate ampk
01/14/16Engineered antibody constant regions for site-specific conjugation and methods and uses therefor
01/07/16Solid forms of a selective cdk4/6 inhibitor
Social Network Patent Pack
01/07/16Carbocyclic- and heterocyclic-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
01/07/16Bispecific heterodimeric diabodies and uses thereof
01/07/16Saccharides and uses thereof
12/31/15N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors
12/31/15Substituted phenyl hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
12/24/15Novel 4-(substituted amino)-7h-pyrrolo[2,3-d]pyrimidines as lrrk2 inhibitors
12/17/15Substituted dihydroisoquinolinone compounds
12/10/15Quinolinyl glucagon receptor modulators
12/10/15Triazine derivatives
12/03/15Compositions and methods for counteracting factor xa inhibition
12/03/15Heteroaromatic compounds and their use as dopamine d1 ligands
12/03/15Heteroaromatic compounds and their use as dopamine d1 ligands
11/26/15Substituted acetyl-coa carboxylase inhibitors
11/26/15Antagonist antibodies against gdf-8 and uses therefor
11/26/15Anti-tofacitinib antibodies and uses thereof for drug monitoring
11/19/15Glycoconjugation process
11/19/15Conjugates and associated methods of producing them for the prevention or treatment of nicotine addiction
11/19/15Pyrazolopyridines and pyrazolopyrimidines
11/19/15Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of asgpr
11/12/15Tropomyosin-related kinase inhibitors
Social Network Patent Pack
11/12/15Azabenzimidazole compounds
11/12/15Engineered monomeric antibody fragments
11/05/15Anti-ptk7 antibody-drug conjugates
10/29/15Muteins of clotting factor vlll
10/29/15Heteroaromatic compounds and their use as dopamine d1 ligands
10/29/15Heteroaromatic compounds and their use as dopamine d1 ligands
10/29/15Cytotoxic peptides and antibody drug conjugates thereof
10/15/15Bruton's tyrosine kinase inhibitors
10/15/15Dihydropyrrolopyrimidine derivatives
10/15/152-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8h)-yl-1,3-thiazol-4-yl amides
10/15/15Heteroaromatic compounds and their use as dopamine d1 ligands
10/15/15Compositions and methods relating to a mutant clostridium difficile toxin
10/15/15Combination of local and systemic immunomodulative therapies for enhanced treatment of cancer
10/15/15Combination of local and systemic immunomodulative therapies for enhanced treatment of cancer
10/08/15Bicyclic-fused heteroaryl or aryl compounds
10/01/15Use of a tetrasubstituted pyrazolo[4, 3-d]pyrimidine compound for treating diabetic nephropathy
10/01/15Process for annealing amorphous atorvastatin
10/01/15Novel chromene and 1,1a,2,7b-tetrahydrocyclopropa[c]chromene pyridopyrazinediones
10/01/15Use of a tetrasubstituted pyrazolo[4, 3-d]pyrimidine compound for treating diabetic nephropathy
09/24/15Glucagon receptor modulators
09/24/15Glucagon receptor modulators
09/24/15Anti-il-13 receptor alpha 2 antibodies and antibody-drug conjugates
09/24/15Antibodies with ph dependent antigen binding
09/17/15Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same
09/17/15Diacylglycerol acyltransferase 2 inhibitors
09/10/15Salt forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid
09/03/15Prostate-associated antigens and vaccine-based immunotherapy regimens
09/03/15Pyrrolo[2,3-d]pyrimidine derivatives
08/27/15Salts and polymorphs of 8-fluoro-2--1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one
08/27/15Benzamide and heterobenzamide compounds
Social Network Patent Pack
08/27/15Alkyl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
08/20/153-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
08/20/15Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
08/13/15Apixaban solution formulations
08/13/15Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
08/13/15Pyrrolo[2,3-d]pyrimidine derivatives
08/06/15Glycoconjugation processes and compositions
08/06/15Binding molecules to the human ox40 receptor
07/30/15Bifunctional cytotoxic agents
07/23/15Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
07/23/15Pyrrolopyrimidine and purine derivatives
07/23/15Antibodies to il-6 and their uses
07/16/15Heteroaromatic compounds and their use as dopamine d1 ligands
07/09/15Compositions and methods for treatment of abnormal cell growth
07/02/15N-link hydroxamic acid derivatives useful as antibacterial agents
07/02/15Compositions comprising heterogeneous populations of recombinant human clotting factor xa proteins
06/25/15Pre moistened wipes for use in treating anal rectal irritations and disorders
06/25/15Aryl and heteroaryl fused lactams
06/25/15Heteroaromatic compounds and their use as dopamine d1 ligands
06/25/15Tricyclic compounds as kat ii inhibitors
06/25/15Circulating tumor cell assay
06/18/15Site-specific integration
06/11/15Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyr-rolo[2,3-d]pyridinyl acrylamides
06/04/15N1/n2-lactam acetyl-coa carboxylase inhibitors
05/28/15Monobactams
05/21/15Purine derivatives
05/14/15Tumor necrosis factor-like ligand 1a specific antibodies and compositions and uses thereof
05/14/15Heterocyclic substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
05/07/15Vectors for expression of prostate-associated antigens







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Pfizer Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Pfizer Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';